Zarbee’s is not FDA approved, and it doesn’t need to be. Most Zarbee’s products are classified as dietary supplements, which fall under a completely different regulatory framework than prescription or over-the-counter drugs. The FDA does not approve dietary supplements before they reach store shelves.
Why the FDA Doesn’t Approve Zarbee’s
Under the Dietary Supplement Health and Education Act (DSHEA), the FDA has no authority to approve dietary supplements before they are marketed. This is fundamentally different from how drugs work. A pharmaceutical drug must be proven safe and effective through clinical trials before it can be sold. A dietary supplement can go straight to market without that process.
That doesn’t mean supplements exist in a regulatory vacuum. The FDA can take action after a product is on the market if it’s found to be unsafe, mislabeled, or making illegal health claims. Manufacturers are responsible for ensuring their products are safe and that their labels are truthful, but nobody at the FDA is reviewing or signing off on those products before you buy them at the pharmacy.
This distinction matters because Zarbee’s packaging and branding can give the impression of a medical product. It sits on the shelf next to actual FDA-regulated cough medicines, it comes in dosing syringes, and it’s marketed for specific symptoms like cough and congestion. But legally, it occupies the same category as a vitamin or herbal capsule.
Zarbee’s Past Issues With the FDA
Zarbee’s has had run-ins with the FDA over how it markets its products. In June 2014, the FDA issued a warning letter to Zarbee’s Naturals Inc. When a dietary supplement is marketed with claims that it treats, prevents, or cures a specific disease, it legally crosses into drug territory and becomes subject to drug regulations. The company made corrective changes, and the FDA closed the matter in March 2018 after evaluating those corrections.
This is a common enforcement pattern with supplement companies. The FDA allows general “structure/function” claims (like “supports immune health”) but draws the line at disease-specific claims (like “treats bronchitis”). That line can be blurry, and companies occasionally cross it.
What “Not FDA Approved” Actually Means for Safety
The lack of FDA approval doesn’t automatically mean a product is dangerous, but it does mean less oversight. No independent government body has verified the ingredients, tested the formulation, or confirmed it works before you give it to yourself or your child.
Safety concerns do come up in this product category. In June 2025, Medtech Products Inc. issued a nationwide recall of Little Remedies Honey Cough Syrup, a competing honey-based cough product, due to contamination with Bacillus cereus, a bacterium that can cause food-borne illness. That recall covered multiple lot numbers with expiration dates ranging from November 2025 through December 2026. While this wasn’t a Zarbee’s product, it illustrates the kinds of risks that exist in a market where pre-market testing isn’t required.
Does the Science Behind the Ingredients Hold Up?
Zarbee’s cough products rely primarily on two ingredients: honey and ivy leaf extract. Both have some clinical evidence behind them, though neither has gone through the rigorous FDA drug approval process.
Honey has been studied for cough relief in children, and several pediatric organizations recognize it as a reasonable option for kids over one year old. It’s generally considered safe in that age group, though it should never be given to infants under 12 months due to the risk of botulism.
Ivy leaf extract has stronger clinical trial data than many people expect. A randomized trial of 325 adults with acute bronchitis, published in the journal Pharmaceuticals, found that a standardized ivy extract reduced bronchitis severity scores by an average of 9.11 points over seven days, compared to 7.64 points for an ivy-and-thyme combination and 8.59 points for a thyme-and-primrose combination. By day seven, 55.4% of patients taking ivy extract alone were considered recovered, compared to 34.1% in the ivy-thyme group. Adverse events were rare and none were serious.
These results are promising, but there’s an important caveat: the specific ivy extract studied (a standardized pharmaceutical preparation called EA 575) may not be identical to what’s in any given Zarbee’s product. Without FDA drug approval, there’s no guarantee that the formulation on the shelf matches the doses and preparations used in clinical research.
How to Read the Label
If you pick up a Zarbee’s product and flip it over, look for the “Supplement Facts” panel. That tells you it’s regulated as a dietary supplement, not a drug. An FDA-approved over-the-counter drug would have a “Drug Facts” panel instead, with standardized sections listing active ingredients, uses, warnings, and dosing instructions in a specific format mandated by the FDA.
You may also notice a small disclaimer on Zarbee’s labels stating something like “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” That disclaimer is required by law on all dietary supplements that make structure or function claims. It’s the clearest signal that you’re holding a product the FDA has not reviewed or approved.